Organic compounds -- part of the class 532-570 series – Organic compounds – Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
2007-05-30
2011-11-01
Kifle, Bruck (Department: 1622)
Organic compounds -- part of the class 532-570 series
Organic compounds
Unsubstituted hydrocarbyl chain between the ring and the -c-...
Reexamination Certificate
active
08049006
ABSTRACT:
A 7-membered heterocyclic compound having the formula (I), or its salt, or a solvate thereof with a chymase inhibitory action and useful for the prevention or treatment of various diseases, in which chymase is involved:a method for producing the same, and a pharmaceutical composition useful for the prevention or treatment of diseases, in which chymase is involved, including the compound of having the formula (I), or its pharmaceutically acceptable salt, or a solvate thereof are provided.
REFERENCES:
patent: 1435408 (2003-08-01), None
patent: 2257171 (1972-11-01), None
patent: 2002-523404 (2002-07-01), None
patent: 2003-342265 (2003-12-01), None
patent: 2004-067584 (2004-03-01), None
patent: 00/51640 (2000-09-01), None
patent: 01/32214 (2001-05-01), None
patent: 01/62292 (2001-08-01), None
patent: 01/62293 (2001-08-01), None
patent: 01/62294 (2001-08-01), None
patent: 02/32881 (2002-04-01), None
patent: 02/083649 (2002-10-01), None
patent: 03/007964 (2003-01-01), None
patent: 03/035654 (2003-05-01), None
patent: 03/078419 (2003-09-01), None
patent: 2004/007464 (2004-01-01), None
patent: 2005/000825 (2005-01-01), None
patent: 2005/021508 (2005-03-01), None
patent: WO 2005/051304 (2005-06-01), None
patent: 2005/073214 (2005-08-01), None
patent: 2005/102389 (2005-11-01), None
patent: 2006/059801 (2006-06-01), None
patent: WO 2006/120544 (2006-11-01), None
Supplementary European Search Report dated Nov. 9, 2009, issued in European Patent Application No. EP 05 81 4413.
Richter et al., “3-Hydroxy-2-methylidenepropionic Acids, A Template for Multiple Core Structure Libraries,” J. Org. Chem., vol. 64, 1999, pp. 1362-1365.
Schechter, Norman, “Chymotrypsin-like Proteinases of Human Skin Mast Cells” in Mast Cell Proteases in Immunology and Biology, Editor, George H. Caughey, 1995, pp. 47-69, Marcel Dekker, Inc., New York, Basel, Hong Kong.
Irani, Anne-Marie A., “Tissue and Developmental Variation of Protease Expression in Human Mast Cells”, in Mast Cell Proteases in Immunology and Biology ed. George H. Caughey, 1995, pp. 127-143, Marcel Dekker, Inc., New York, Basel, Hong Kong.
Urata et al., “Identification of a Highly Specific Chymase as the Major Angiotensin II-forming Enzyme in the Human Heart”, Journal of Biological Chemistry, Dec. 25, 1990, pp. 22348-22357, vol. 265, No. 36, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Vartio et al., “Susceptibility of Soluble and Matrix Fibronectins to Degradation by Tissue Proteinases, Mast Cell Chymase and Cathepsin G”, Journal of Biological Chemistry, Jan. 10, 1981, pp. 471-477, vol. 256, No. 1. USA.
Saarinen, Juhani et al., “Activation of Human Intersititial Procollagenase through Direct Cleavage of the Leu83-Thr84Bond by Mast Cell Chymase”, Journal of Biological Chemistry, Jul. 8, 1994, pp. 18134-18140, vol. 269, No. 27, The American Society for Biochemistry and Molecular Biology, Inc., USA.
Kofford et al., “Cleavage of Type I Procollagen by Human Mast Cell Chymase Initiates Collagen Fibril Formation and Generates a Unique Carboxyl-terminal Propetide”, Journal of Biological Chemistry, Mar. 14, 1997, pp. 7127-7131, vol. 272, No. 11; The American Society for Biochemistry and Molecular Biology, Inc., USA.
Taipale et al., “Human Mast Cell Chymase and Leukocyte Elastase Release Latent Transforming Growth Factor β1 from the Extracellular Matrix of Cultured Human Epithelial and Endothelial Cells”, Journal of Biological Chemistry, Mar. 3, 1995, pp. 4689-4696, vol. 270, No. 9; The American Society for Biochemistry and Molecular Biology, Inc., USA.
Lindstedt et al., “Activation of Paracrine TGF-β1 Signaling Upon Stimulation and Degranulation of Rat Serosal Mast Cells: A Novel Function for Chymase”, The FASEB Journal, Jun. 2001, vol. 15, pp. 1377-1388.
Mizutani et al., “Rapid and Specific Conversion of Precursor Interleukin 1β (IL-1β) to an Active IL-1 Species by Human Mast Cell Chymase”, J. Exp. Med, Oct. 1991, pp. 821-825, vol. 174; The Rockefeller University Press.
Longley et al., “Chymase Cleavage of Stem Cell Factor Yields a Bioactive, Soluble Product”, Proc. National Academy of Science, USA; Aug. 1997, vol. 94, pp. 9017-9021.
Kokkonen et al., “Low Density Lipoprotein Degradation by Secretory Granules of Rat Mast Cells”, Journal of Biological Chemistry; vol. 261, No. 34, Dec. 5, 1986; pp. 16067-16072; The American Society of Biological Chemists, Inc.
Lindstedt et al., “Chymase in Exocytosed Rat Mast Cell Granules Effectively Proteolyzes Apolipoprotein A1-containing Lipoproteins, So Reducing the Cholesterol Efflux-inducing Ability of Serum and Aortic Intimal Fluid”, J. Clin. Invest., vol. 97, No. 10, May 1996, pp. 2174-2182; The American Society for Clinical Investigation, Inc.
Nakano et al., “Selective Conversion of Big Endothelins to Tracheal Smooth Muchle-Constricting 31-Amino Acid-Length Endothelins by Chymase from Human Mast Cells”; J. Immunology; vol. 159; 1997; pp. 1987-1992.
Schick et al., “Rat Serosal Mast Cell Degranulation Mediated by Chymase, An Endogenous Secretory Granule Protease: Active Site-Dependent Initiation at 1° C”; The Journal of Immunology; vol. 136, No. 10, May 15, 1986, pp. 3812-3818.
He et al., Human Mast Cell Chymase Induces the Accumulation of Neutrophils, Eosinophils and Other Inflammatory Cells in vivo; British Journal of Pharmacology, (1998) 125, pp. 1491-1500.
He et al., “The Induction of a Prolonged Increase in Microvascular Permeability by Human Mast Cell Chymase”; Elsevier, European Journal of Pharmacology 352 (1998) pp. 91-98.
Powers et al., “Inhibitors of Serine Proteinases” in Proteinase Inhibitors, pp. 55-152; (1986), Editors Barrett and Salvensen.
Fukami et al., “Chymase: Its Pathophysiological Roles and Inhibitors”; Curr. Pharmaceutical Design, vol. 4; Institute for Biomedical Research, Research Center, Suntory Ltd, Japan; 1998; pp. 439-453.
Aoyama, “Non-Peptidic Chymase Inhibitors”; Ashley Publications; 2001; pp. 1423-1429.
Muto et al., “Recent Chymase Inhibitors and Their Effects in in vivo Models”; IDrugs 2002 5(12); pp. 1141-1150.
Matsumoto et al., “Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure”; Circulation, vol. 107; May 27, 2003; pp. 2555-2558.
Jin et al., “Beneficial Effects of Cardiac Chymase Inhibition During the Acute Phase of Myocardial Infarction”; Life Sciences 71 (2002) pp. 437-446.
Takai et al., “A Single Treatment With a Specific Chymase Inhibitor, TY-51184, Prevents Vascular Proliferation in Canine Grafted Veins”; J. Pharmacological Sciences (2004); vol. 94, pp. 443-448.
Lampariello et al., “Solid-Phase Synthesis of Conformationally Constrained Peptidomimetics Based on a 3,6-Disubstituted-1,4-diazepan-2,5-dione Core”; J. Org. Chem. (2003); vol. 68, pp. 7893-7895.
Müller-Hartwieg et al., “Synthesis and Conformational Investigation of Cyclic Dipeptides: 7-Membered Rings Containing α- and β-Amino Acids”; Journal of Peptide Science; (2003) vol. 9, pp. 187-199.
Search Report dated Jul. 3, 2007 for International Application No. PCT/JP2006/061406 filed May 30, 2007.
M. Gates et al., “New Synthesis of Diazepam,” The Journal of Organic Chemistry, 1980, pp. 1675-1681, vol. 45, No. 45, American Chemical Society, Columbus, OH (US).
H. Ritcher et al., “Polymer Bound 3-Hydroxy 2-methylidenepropionic Acids. A Template for Multiple Core Structure Libraries,” The Journal of Organic Chemistry, 1999, pp. 1362-1365, vol. 64, No. 4, American Chemical Society, Columbus, OH (US).
European Search Report dated Nov. 9, 2009, issued in European Patent Application No. EP 07 74 4751.
Hoen et al., “Enantioselective synthesis of β2-amino acids using rhodium-catalyzed hydrogenation,”Org. Biom
Imajo Seiichi
Maruoka Hiroshi
Muto Tsuyoshi
Sato Koji
Tanaka Taisaku
Daiichi Sankyo Company, Limited
Drinker Biddle & Reath LLP
Kifle Bruck
LandOfFree
7-membered ring compound and method of production and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-membered ring compound and method of production and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-membered ring compound and method of production and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4294442